Efficacy and Safety of Aspirin Therapy With CABG

• Status: Unknown status
• Trial end date: 2018-01-01
• Target enrollment: 0
• Participant gender: All

Summary

evaluate the safety of preoperative aspirin therapy when performing bypass surgery in conditions of artificial blood circulation

• Phase: Phase 3
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Meshalkin Research Institute of Pathology of Circulation
• Treatments: Aspirin

Criteria

Inclusion Criteria:

• Patients 18 years of age or older

• Patient able to give informed consent

Exclusion Criteria:

• Missing consent

• Urgent or emergent surgery

• Off-pump CABG

• Рatient has clear indication for anticoagulation (eg. mechanical heart valve, atrial fibrillation) or ADP receptor antagonist (eg. drug-eluting stent)

• History of bleeding diathesis, significant GI bleed, ICH, or liver failure

• Allergy to or intolerance of aspirin